Hepcidin Levels in Periodontal Health and Disease
NCT03789565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2019-10-04
Summary
Periodontal disease refers to inflammatory disease of the periodontium caused by the host and/or pathogenic microorganisms. Anti-inflammatory and pro-inflammatory cytokines play a role in the periodontal inflammation process. The aim of this study was to evaluate the levels of hepcidin, interleukin (IL)-6, and IL-10 levels in gingival crevicular fluid (GCF) and in serum samples obtained from individuals with periodontal inflammation.
Conditions
- Periodontal Diseases
Interventions
- OTHER
-
Biomarker test
Diagnostic biomarker study
Sponsors & Collaborators
-
Bulent Ecevit University
lead OTHER
Eligibility
- Min Age
- 32 Years
- Max Age
- 52 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-15
- Primary Completion
- 2018-01-20
- Completion
- 2018-02-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Chemerin and Interleukin-6 Levels of Gingival Crevicular Fluid in Obese Individuals Following Periodontal Treatment
NCT02660814 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Chemerin and IL-6 Levels in Diabetes and Periodontitis
NCT02596581 ·Status: COMPLETED ·Phase: NA
-
Activin-A and Interleukin-1β Levels in Periodontitis
NCT06110221 ·Status: COMPLETED
-
IL-10, IL-12 and IL-18 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and Healthy Controls
NCT05307068 ·Status: COMPLETED
-
Evaluation of Biomarkers Levels in Gingival Crevicular Fluid, Saliva and Serum for Different Periodontal Diseases
NCT05435131 ·Status: COMPLETED ·Phase: NA
-
Interleukin-38 Levels in Individuals With Periodontitis
NCT05568290 ·Status: UNKNOWN
-
EVALUATION OF SALIVARY BİOMARKER LEVELS IN SMOKING AND NON-SMOKER INDIVIDUALS WITH DIFFERENT PERIODONTAL DISEASES
NCT06971770 ·Status: COMPLETED ·Phase: NA
-
GCF Levels of IL-1β and IL-6 in Gingivitis and Stage III-Grade C Periodontitis
NCT04689438 ·Status: COMPLETED
-
Gingival Crevicular Fluid (GCF) Bactericidal Permeability Protein (BPI) and Interleukin (IL)-1 Beta
NCT06295666 ·Status: COMPLETED
-
IL-32 Isoforms Levels in GCF and Plasma of the Patients With Periodontitis
NCT04350489 ·Status: COMPLETED
-
Oral and Systemic Levels of TFF-1 and TTF-3 in Periodontal Diseases
NCT04407026 ·Status: COMPLETED
-
Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions
NCT06961409 ·Status: RECRUITING
-
Evaluation of Biomarker Levels in Gingival Crevicular Fluid of Patients With Different Periodontal Diseases
NCT04777487 ·Status: COMPLETED ·Phase: NA
-
GCF Levels of Chemokines in Periodontitis
NCT06291454 ·Status: COMPLETED
-
Gingival Crevicular Fluid, Salivary, and Serum Biomarkers Levels in Periodontal Treatment
NCT05395455 ·Status: COMPLETED ·Phase: NA
-
YKL-40 and IL-6 Levels in Periodontal Disease
NCT03507868 ·Status: COMPLETED
-
Gingival Crevicular IL-34 and CSF-1 Levels in Patients With Periodontitis and Uncontrolled Type 2 Diabetes
NCT04891627 ·Status: COMPLETED
-
Chemerin, Fetuin-A, IL-34 and IL-13 Levels in Diabetic Periodontitis Patients
NCT06135532 ·Status: COMPLETED ·Phase: NA
-
Gingival Crevicular Fluid and Salivary Levels of GDF-15, Smad2, Smad5, Smad6, and IL-6 in Patients With Periodontitis
NCT07201142 ·Status: COMPLETED
-
Investigation of Lipoxin A4, Annexin A1 and Interleukin-1 Beta Levels in Individuals With Periodontitis.
NCT06700161 ·Status: COMPLETED
-
Assessment of Salivary Biomarker Levels in Individuals With Various Periodontal Diseases
NCT07025291 ·Status: COMPLETED ·Phase: NA
-
GCF Levels of IL-1Beta, MIP-1 Alfa and G-CSF in Gingivitis and Stage I-II-III-IV Periodontitis Patients
NCT04629313 ·Status: COMPLETED
-
Meteorin-like Levels in Individuals With Periodontitis
NCT04402996 ·Status: COMPLETED
-
Analysis of the Impact of Contemporary Subgingival Debridement Techniques on Immunological Biomarkers in Gingival Crevicular Fluid
NCT07243145 ·Status: COMPLETED
-
IL-32 Levels in Patients With Chronic Periodontitis
NCT02632981 ·Status: COMPLETED ·Phase: PHASE1